Matrix metalloproteinase-2 and-9 levels in obese patients
Matrix metalloproteinase-2 and-9 levels in obese patients
复制标题
DOI:
10.1080/10623320802228815
复制
发表时间:
2008-01-01
影响因子:
--
通讯作者:
Cicero, A. F. G.
中科院分区:
文献类型:
--
作者:
Derosa, G.;Ferrari, I.;Cicero, A. F. G.
The data reported in literature revealed a novel function for matrix metalloproteinases ( MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue development remain poorly defined. The authors hypothesized that MMP-2 and MMP-9 levels might be abnormal in obesity, reflecting alterations in extracellular matrix (ECM) turnover. One hundred and sixty three obese patients and 165 controls were enrolled. The following were measured: body mass index (BMI), waist circumference (WC), fasting plasma glucose (FPG), fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), lipoprotein(a) (Lp(a)), and plasma levels of MMP-2 and MMP-9. A significant increase of BMI and WC (p